1. Home
  2. CLGN vs DKI Comparison

CLGN vs DKI Comparison

Compare CLGN & DKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$3.47

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

DKI

DarkIris Inc. Class A Ordinary Shares

N/A

Current Price

$2.45

Market Cap

5.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CLGN
DKI
Founded
2004
2018
Country
Israel
Hong Kong
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
5.9M
IPO Year
2015
2025

Fundamental Metrics

Financial Performance
Metric
CLGN
DKI
Price
$3.47
$2.45
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
9.8M
28.9K
Earning Date
05-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$240.45
N/A
Revenue Next Year
$38.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.28
52 Week High
$3.91
$11.80

Technical Indicators

Market Signals
Indicator
CLGN
DKI
Relative Strength Index (RSI) 91.98 23.39
Support Level $0.34 $0.34
Resistance Level N/A $5.20
Average True Range (ATR) 0.20 0.25
MACD 0.39 -0.10
Stochastic Oscillator 89.30 0.57

Price Performance

Historical Comparison
CLGN
DKI

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

About DKI DarkIris Inc. Class A Ordinary Shares

Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.

Share on Social Networks: